Filing Flows › Comparisons › IVF vs NMTC
Invo Fertility vs Neuroone Medical Technologies: IVF and NMTC compared
Invo Fertility is the larger company: $2.2M of revenue in its latest quarter (Q2 2026) against $2.0M for Neuroone Medical Technologies (Q3 FY26). Invo Fertility is growing faster (+17% against +16% a year earlier). Invo Fertility is more profitable, with an operating margin of -59.3% against -122.9%.
Where the money goes: IVF and NMTC
Invo Fertility (IVF) · Q2 2026
Invo Fertility, Q2 2026: revenue $2.2M (+17% year over year), operating margin -59.3%, net earnings $889K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
Neuroone Medical Technologies (NMTC) · Q3 FY26
Neuroone Medical Technologies, Q3 FY26: revenue $2.0M (+16% year over year), operating margin -122.9%, net loss $2.0M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| Invo Fertility (IVF) | Neuroone Medical Technologies (NMTC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 FY26 |
| Revenue | $2.2M | $2.0M |
| Revenue growth, Y/Y | +17% | +16% |
| Operating margin | -59.3% | -122.9% |
| Net earnings | $889K | −$2.0M |
| Net margin | 40.9% | -101.7% |
| Operating cash flow | −$1.1M | −$1.1M |
Where the revenue comes from
Invo Fertility
- Clinic Revenue: $2.2M (100%)
- Product: $8K (0%)
Questions
Which is bigger, Invo Fertility or Neuroone Medical Technologies?
Invo Fertility is the larger company: $2.2M of revenue in its latest quarter (Q2 2026) against $2.0M for Neuroone Medical Technologies (Q3 FY26).
Is Invo Fertility or Neuroone Medical Technologies growing faster?
Invo Fertility is growing faster (+17% against +16% a year earlier).
Which is more profitable, Invo Fertility or Neuroone Medical Technologies?
Invo Fertility is more profitable, with an operating margin of -59.3% against -122.9%.
More: Invo Fertility earnings · how Invo Fertility makes money · Neuroone Medical Technologies earnings · how Neuroone Medical Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.